<div id="readability-page-1">05:35 AM EST, 01/12/2026 (MT Newswires) -- RxSight ( RXST ) , an ophthalmic medical device company, said Sunday it has appointed Mark Wilterding as chief financial officer, starting January 11.Wilterding, who has more than 25 years of financial leadership experience, most recently served as senior vice president of global finance at Edwards Lifesciences. He previously worked at Medtronic and began his career in banking at Citi and Credit Suisse.RxSight ( RXST ) said previously announced plans for former CFO Shelley Thunen to continue supporting the company in a consulting capacity remain in place. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

RXST

RxSight 已任命 Mark Wilterding 為新的首席財務官，任職時間從 2026 年 1 月 11 日開始。Wilterding 擁有超過 25 年的財務領導經驗，曾擔任 Edwards Lifesciences 的全球財務高級副總裁，並在 Medtronic、Citi 和瑞士信貸工作。公司確認，前首席財務官 Shelley Thunen 將繼續以顧問身份支持 RxSight

RxSight 任命 Mark Wilterding 為首席財務官